Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial.

Kara W ChewBabafemi O TaiwoCarlee B MoserEric S DaarDavid Alain WohlJustin RitzArzhang Cyrus JavanJonathan Z LiWilliam A FischerAlexander L GreningerChristoph BauschThomas LukeRobert CallGene NeytmanMark J GigantiCourtney V FletcherMichael D HughesJoseph J EronJudith S CurrierDavey M Smithnull null

Published in: The Journal of infectious diseases (2024)

SAB-185 had an acceptable safety profile with faster symptom resolution in the Omicron population. Additional studies are needed to characterize its efficacy for COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
single molecule
case control
patient reported